Expression profile of the S100 gene family members in oral squamous cell carcinomas

Journal of Oral Pathology and Medicine

Volumn 37, Issue 10, 2008, Pages 607-615

  Sapkota, Dipak ^a   Bruland, Ove ^b   Bøe, Olav E ^c   Bakeer, Hala ^d   Elgindi, Osman A A ^d   Vasstrand, Endre N ^a   Ibrahim, Salah O ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d Khartoum Dental Teaching Hospital   (Sudan)

Author keywords

Down regulation; Oral squamous cell carcinomas; RT PCR; S100; Sudan

Indexed keywords

CALCYCLIN; CALGRANULIN A; CALGRANULIN B; CALVASCULIN; MESSENGER RNA; PROTEIN S 100; PROTEIN S100B; S100A1 PROTEIN; S100A10 PROTEIN; S100A11 PROTEIN; S100A12 PROTEIN; S100A13 PROTEIN; S100A14 PROTEIN; S100A2 PROTEIN; S100A3 PROTEIN; S100P PROTEIN; S100Z PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MALE; MARKER GENE; MOUTH CARCINOMA; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SUDAN; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S100 PROTEINS; SUDAN; TOBACCO, SMOKELESS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 53549120627     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00683.x     Document Type: Article

References (59)

1. Dobrossy L. Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 2005 24 : 9 17.
2. Wong DTW, Todd R, Tsuji T, Donoff RB. Molecular biology of human oral cancer. Crit Rev Oral Biol Med 1996 7 : 319 28.
3. Johnson N. Tobacco use and oral cancer: a global perspective. J Dent Educ 2001 65 : 328 39.
4. Kademani D. Oral cancer. Mayo Clin Proc 2007 82 : 878 87.
5. Massano J, Regateiro FS, Januario G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 102 : 67 76.
6. Tralongo V, Rodolico V, Luciani A, Marra G, Daniele E. Prognostic factors in oral squamous cell carcimoma. A review of the literature. Anticancer Res 1999 19 : 3503 10.
7. Silverman SJ. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 2001 132 (Suppl 7S 11S.
8. Dysvik B, Vasstrand EN, Lovlie R, et al. Gene expression profiles of head and neck carcinomas from Sudanese and Norwegian patients reveal common biological pathways regardless of race and lifestyle. Clin Cancer Res 2006 12 : 1109 20.
9. Ibrahim SO, Aarsaether N, Holsve MK, et al. Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: the case of the Sudan vs. Norway Oral Oncol 2003 39 : 37 48.
10. Idris AM, Ahmed HM, Malik MOA. Toombak dipping and cancer of the oral cavity in the Sudan: a case-control study. Int J Cancer 1995 63 : 477 80.
11. Idris AM, Ahmed HM, Mukhtar BI, Gadir AF, El-Beshir EI. Descriptive epidemiology of oral neoplasms in Sudan 1970-1985 and the role of toombak. Int J Cancer 1995 61 : 155 8.
12. Williams HK. Molecular pathogenesis of oral squamous carcinoma. Mol Pathol 2000 53 : 165 72.
13. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications. Oral Oncol 2000 36 : 404 13.
14. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 2000 36 : 311 27.
15. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 2000 36 : 256 63.
16. Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS. Calcium-dependent and -independent interactions of the S100 protein family. Biochem J 2006 396 : 201 14.
17. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003 60 : 540 51.
18. Tsai WC, Tsai ST, Jin YT, Wu LW. Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma. Mol Cancer Res 2006 4 : 539 47.
19. Heizmann CW, Fritz G, Schafer BW. S100 proteins: structure, functions and pathology. Front Biosci 2002 7 : 1356 68.
20. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001 33 : 637 68.
21. Tsai ST, Jin YT, Tsai WC, et al. S100A2, a potential marker for early recurrence in early-stage oral cancer. Oral Oncol 2005 41 : 349 57.
22. Moriyama-Kita M, Endo Y, Yonemura Y, et al. S100A4 regulates E-cadherin expression in oral squamous cell carcinoma. Cancer Lett 2005 230 : 211 8.
23. Moriyama-Kita M, Endo Y, Yonemura Y, et al. Correlation of S100A4 expression with invasion and metastasis in oral squamous cell carcinoma. Oral Oncol 2004 40 : 496 500.
24. Banerjee AG, Bhattacharyya I, Vishwanatha JK. Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia. Mol Cancer Ther 2005 4 : 865 75.
25. Ji J, Zhao L, Wang X, et al. Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2004 130 : 480 6.
26. Cross SS, Hamdy FC, Deloulme JC, Rehman I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 2005 46 : 256 69.
27. Berta GN, Ghezzo F, D'Avolio A, et al. Enhancement of calcyclin gene RNA expression in squamous cell carcinoma of the oral mucosa, but not in benign lesions. J Oral Pathol Med 1997 26 : 206 10.
28. Roesch Ely M, Nees M, Karsai S, et al. Transcript and proteome analysis reveals reduced expression of calgranulins in head and neck squamous cell carcinoma. Eur J Cell Biol 2005 84 : 431 44.
29. Suhr ML, Dysvik B, Bruland O, et al. Gene expression profile of oral squamous cell carcinomas from Sri Lankan betel quid users. Oncology Rep 2007 18 : 1061 75.
30. Cho YG, Kim CJ, Nam SW, et al. Overexpression of S100A4 is closely associated with progression of colorectal cancer. World J Gastroenterol 2005 11 : 4852 6.
31. Davies BR, O'Donnell M, Durkan GC, et al. Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer. J Pathol 2002 196 : 292 9.
32. Cho YG, Nam SW, Kim TY, et al. Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. APMIS 2003 111 : 539 45.
33. Gupta S, Hussain T, MacLennan GT, Fu P, Patel J, Mukhtar H. Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. J lin Oncol 2003 21 : 106 12.
34. Garrett SC, Varney KM, Weber DJ, Bresnick AR. S100A4, a mediator of metastasis. J Biol Chem 2006 281 : 677 80.
35. Helfman DM, Kim EJ, Lukanidin E, Grigorian M. The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 2005 92 : 1955 8.
36. Hemandas AK, Salto-Tellez M, Maricar SH, Leong AFPK, Leow CK. Metastasis-associated protein S100A4 - a potential prognostic marker for colorectal cancer. J Surg Oncol 2006 93 : 498 503.
37. Matsumoto K, Irie A, Satoh T, et al. Expression of S100A2 and S100A4 predicts for disease progression and patient survival in bladder cancer. Urology 2007 70 : 602 7.
38. Emberley ED, Murphy LC, Watson PH. S100 proteins and their influence on pro-survival pathways in cancer. Biochem Cell Biol 2004 82 : 508 15.
39. Grigorian M, Andresen S, Tulchinsky E, et al. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 2001 276 : 22699 708.
40. Rehman I, Goodarzi A, Cross SS, et al. DNA methylation and immunohistochemical analysis of the S100A4 calcium binding protein in human prostate cancer. Prostate 2007 67 : 341 7.
41. Lindsey JC, Lusher ME, Anderton JA, Gilbertson RJ, Ellison DW, Clifford SC. Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma. Br J Cancer 2007 97 : 267 74.
42. Tulchinsky E, Grigorian M, Tkatch T, Georgiev G, Lukanidin E. Transcriptional regulation of the mts1 gene in human lymphoma cells: the role of DNA-methylation. Biochim Biophys Acta 1995 1261 : 243 8.
43. Rosty C, Ueki T, Argani P, et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol 2002 160 : 45 50.
44. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1999 1450 : 191 231.
45. Heizmann CW, Cox JA. New perspectives on S100 proteins: a multi-functional Ca(2+)-, Zn(2+)- and Cu(2+)-binding protein family. Biometals 1998 11 : 383 97.
46. Luu HH, Zhou L, Haydon RC, et al. Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett 2005 229 : 135 48.
47. Rehman I, Cross SS, Azzouzi AR, et al. S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. Br J Cancer 2004 91 : 739 44.
48. Ohuchida K, Mizumoto K, Ishikawa N, et al. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin Cancer Res 2005 11 : 7785 93.
49. Komatsu K, Andoh A, Ishiguro S, et al. Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas. Clin Cancer Res 2000 6 : 172 7.
50. Lesniak W, Slomnicki LP, Kuznicki J. Epigenetic Control of the S100A6 (Calcyclin) Gene Expression. J Invest Dermatol 2007 127 : 2307 14.
51. Gebhardt C, Nemeth J, Angel P, Hess J. S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 2006 72 : 1622 31.
52. Thorey IS, Roth J, Regenbogen J, et al. The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes. J Biol Chem 2001 276 : 35818 25.
53. Hermani A, Hess J, De Servi B, et al. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin Cancer Res 2005 11 : 5146 52.
54. El-Rifai W, Moskaluk CA, Abdrabbo MK, et al. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res 2002 62 : 6823 6.
55. 2+ relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 2004 23 : 1291 9.
56. Fung LF, Lo AK, Yuen PW, Liu Y, Wang XH, Tsao SW. Differential gene expression in nasopharyngeal carcinoma cells. Life Sci 2000 67 : 923 36.
57. Pietas A, Schluns K, Marenholz I, Schafer BW, Heizmann CW, Petersen I. Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the S100 family. Genomics 2002 79 : 513 22.
58. Yao R, Lopez-Beltran A, MacLennan GT, Montironi R, Eble JN, Cheng L. Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res 2007 27 : 3051 8.
59. Folgueira MA, Brentani H, Katayama ML, et al. Gene expression profiling of clinical stages II and III breast cancer. Braz J Med Biol Res 2006 39 : 1101 13.